finanzen.net
04.12.2019 00:20
Bewerten
(0)

The global neurology devices market at a CAGR of almost 12% during the forecast period

NEW YORK, Dec. 3, 2019 /PRNewswire/ --

Global Neurology Devices Market: About this market
This neurology devices market analysis considers sales from neurostimulation devices, interventional neurology devices, neurosurgery devices, cerebrospinal fluid management devices, and other products. Our study also finds the sales of neurology devices in Asia, Europe, North America, and ROW. In 2019, the neurostimulation devices segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as implantable, programmable devices placed surgically to deliver electrical stimulation to the intended parts of the brain, the spinal cord will play a significant role in the neurostimulation devices segment to maintain its market position. Also, our global neurology devices market report looks at factors such as increasing prevalence of neurological disorders, growing geriatric population, increasing funding on neurology. However, high cost of neurology devices, stringent regulations, and product recall, and shortage of neurologists may hamper the growth of the neurology devices industry over the forecast period.

Read the full report: https://www.reportlinker.com/p05829116/?utm_source=PRN

Global Neurology Devices Market: Overview
Increasing prevalence of neurological disorders
The prevalence of neurological disorders which include PD, MS, sleep apnea, epilepsy, brain tumors, brain aneurysm, brain stroke, and brain tumors is increasing. These disorders are associated with the central and peripheral nervous systems. Patients experience pain, neurological instability, seizures, paralysis, and muscle weakness under these conditions. Several factors including chromosomal abnormalities or congenital defects in genes cause these neurological conditions. Thus, the increasing prevalence of neurological disorders will lead to the expansion of the global neurology devices market at a CAGR of almost 12% during the forecast period.

Strong prevalence of the wearable neurology devices
The growing awareness and need for home care have encouraged the global population to adopt smart wearable devices such as smartwatches and smart bands for seamless monitoring and recording of patient health data through a wireless interface. Additionally, the recorded health data can be shared with healthcare professionals for better patient outcomes. Wearable neurology devices are used for continuous detection and monitoring of patients with neurological disorders such as seizures and PD. The US FDA has already approved an MHealth wearable device, Embrace2, which uses advanced machine learning technology to detect electrodermal activities in patients. This development is expected to have a positive impact on the overall market growth.

Competitive Landscape
With the presence of several major players, the global neurology devices market is fragmented. This robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading neurology devices manufacturers, that include Abbott Laboratories, B. Braun Melsungen AG, Becton, Dickinson and Co., Boston Scientific Corp., Johnson & Johnson Services Inc., Medtronic Plc, MicroPort Scientific Corp., Nihon Kohden Corp., Penumbra Inc., and Stryker Corp.

Also, the neurology devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

Read the full report: https://www.reportlinker.com/p05829116/?utm_source=PRN

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

Cision View original content:http://www.prnewswire.com/news-releases/the-global-neurology-devices-market-at-a-cagr-of-almost-12-during-the-forecast-period-300968566.html

SOURCE Reportlinker

Chance-Risiko-Profil

Für viele Anleger sieht die ideale Geldanlage so aus: sicher wie eine Anleihe und gleichzeitig renditestark wie eine Aktie. Zertifikate können diee Rolle übernehmen. Wie Sie das Chance-Risiko-Profil Ihres Wertpapierdepots mit Zertifikaten justieren, verrät Ihnen Anlageprofi Anouch Wilhelms von der Commerzbank am Mittwochabend.

Jetzt kostenlos anmelden!
Werbung
Werbung
Börse Stuttgart Anlegerclub

Die richtige Strategie für die Börsenkrise

Stecken Sie nicht den Sand in den Kopf, sondern kaufen Sie die richtigen Aktien. Erfahren Sie im aktuellen Anlegermagazin mehr über attraktive Qualitätsaktien und zyklische Aktien
Kostenfrei registrieren und lesen!

Heute im Fokus

DAX schließt mit roten Vorzeichen -- US-Börsen unverändert -- K+S: Ziele in Gefahr -- Amazon bekommt CL-Rechte -- Deutsche Bank: Gegenwind bei Radikalumbau -- LEONI, JUST EAT, Sanofi, JOST im Fokus

Pfeiffer Vacuum-Aktie auf Talfahrt - Verkaufsempfehlung der DZ Bank. US-Investor KKR nimmt letzte Hürde bei Springer-Einstieg. Brandenburg hofft auf BASF-Batteriefabrik. EZB senkt Kapitalanforderung für Deutsche Bank leicht. Amazon: Druck Trumps schuld an verlorenem Pentagon-Milliardenauftrag. Apple Pay startet bei Sparkassen und weiteren Banken.

Die 5 beliebtesten Top-Rankings

Die Performance der DAX 30-Werte im November 2019.
Welche Aktie macht das Rennen?
Die Performance der Rohstoffe in in KW 49 2019.
Welcher Rohstoff macht das Rennen?
Das hat sich geändert
Diese Aktien hat George Soros im Depot
Das sind die reichsten Länder Welt 2019
Deutschland gerade noch in den Top 20
Hohe Gehälter:
Welche Arbeitgeber am meisten zahlen
mehr Top Rankings

Umfrage

Was wünschen Sie sich von der Großen Koalition?

Online Brokerage über finanzen.net

finanzen.net Brokerage
Handeln Sie für nur 5 Euro Orderprovision* pro Trade aus der Informationswelt von finanzen.net!

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln
Kontakt - Impressum - Werben - Pressemehr anzeigen
Top News
Beliebte Suchen
DAX 30
Öl
Euro US-Dollar
Bitcoin
Goldpreis
Meistgesucht
Wirecard AG747206
Deutsche Bank AG514000
Daimler AG710000
Varta AGA0TGJ5
NEL ASAA0B733
EVOTEC SE566480
Apple Inc.865985
BASFBASF11
Amazon906866
Ballard Power Inc.A0RENB
Microsoft Corp.870747
CommerzbankCBK100
Deutsche Telekom AG555750
Allianz840400
Infineon AG623100